It was recently shown that Mycobacterium tuberculosis produces cellulose which forms an integral part of its extracellular polymeric substances within a biofilm set-up. Using Mycobacterium smegmatis as a proxy model organism, we demonstrate that M. smegmatis biofilms treated with purified MSMEG_6752 releases the main cellulose degradation-product (cellobiose), detected by using ionic chromatography, suggesting that MSMEG_6752 encodes a cellulase. Its overexpression in M. smegmatis prevents spontaneous biofilm formation. Moreover, the method reported here allowed detecting cellobiose when M. smegmatis cultures were exposed to a subinhibitory dose of rifampicin. Overall, this study highlights the role of the MSMEG_6752 in managing cellulose production induced during biofilm formation and antibiotic stress response.
Introduction
Even though mycobacteria belong to Actinobacteria, a phylum comprising of many soil cellulolytic bacteria such as Streptomyces spp., no mycobacteria have ever been reported to be cellulolytic (defined as being capable of utilizing a crystalline source of cellulose as sole carbohydrate source) (Koeck et al. 2014) . However, the sequencing of mycobacterial genomes has revealed cellulase-encoding genes and the crystal structure and the biochemical characterization of the glycoside hydrolase (GH) family 6 endoglucanase of Mycobacterium tuberculosis CelA (encoded by Rv0062) have been reported (Varrot et al. 2005 ). Many hypotheses have been given on why mycobacteria retained cellulase-encoding genes while the M. tuberculosis decaying genome lost many other plant cell wall-hydrolyzing enzymes still encoded by other Actinobacteria. None of them has been challenged by any experimental evidence. Since noncellulolytic organisms can team up with true cellulolytic organisms within a complex community in order to hydrolyze a crystalline source of cellulose (Kato et al. 2005) , it is conceivable that some mycobacteria may employ a similar strategy. This may be the case in the gut environment since Mycobacterium spp., including M. tuberculosis, can be isolated from fecal samples of humans and other animals (El Khéchine et al. 2009; Yin et al. 2015) .
Remarkably, a recent study demonstrated that M. tuberculosis produces cellulose filaments, shown to play a central role in the structural integrity of its biofilms (Trivedi et al. 2016) . Studies on mycobacterial biofilms are numerous and often report on the increase in antimicrobial tolerance that biofilms possess compared to planktonic cells (Ojha et al. 2008; Islam et al. 2012) . Biofilm formation in mycobacteria is a complex process that includes many genes and pathways (Recht and Kolter 2001; Ojha et al. 2005) . In many proteobacteria, the role that cellulose plays in biofilm biology is well-documented (Limoli et al. 2015) and it is generally perceived that cellulose provides tensile strength to the biofilm structures.
Herein, we aimed at clarifying the potential impact of a mycobacterial cellulase and degradation of cellulose whose production is induced under specific growth conditions. We characterized and addressed the role the MSMEG_6752 cellulase from Mycobacterium smegmatis in relation to biofilm-and rifampicin-induced cellulose induction.
Results

MSMEG_6752 encodes an endoglucanase akin to Rv0062
Multiple sequence alignments indicate that M. smegmatis MSMEG_6752 from GH6 family shares 67% identity and 88% similarity with the already-characterized M. tuberculosis Rv0062 (or CelA) protein ( Figure 1A ), a bona fide GH6 endoglucanase with activity demonstrated on several cellulose-like substrates (Varrot et al. 2005) . That all the residues involved in catalysis and/or in binding of the carbohydrate substrate in the crystal structure of Rv0062 were found to be conserved in MSMEG_6752 ( Figure 1A ), suggests that MSMEG_6752 may also exhibit cellulase activity. To confirm this hypothesis, the M. smegmatis MSMEG_6752 and M. tuberculosis Rv0062 genes were cloned in pET32 and introduced in Escherichia coli Rosetta II for protein expression. Relatively high titers of recombinant MSMEG_6752 ( Figure 1B ) and Rv0062 (not shown) were obtained under the conditions used. Purified MSMEG_6752 and Rv0062 exhibited carboxymethyl cellulase (CMCase) activity on all the pHs tested, ranging from pH 3.0 to pH 7.0. The specific activity for each enzyme was~10% higher at pH 5.0 than at pH~7.0 in which all the culturing conditions were conducted ( Figure 1C ). In addition, like with Rv0062, the activity of MSMEG_6752 was demonstrated on cellulose with the release of cello-oligosaccharides from phosphoric acid swollen cellulose (PASC) ( Figure 1D ). Cello-oligosaccharides from a degree of polymerization (DP), ranging from DP2 to DP5, were identified based on standards, indicating that MSMEG_6752 encodes an endoglucanase akin to Rv0062 (Varrot et al. 2005) .
The M. smegmatis genome does not predict any other β-glucanase-encoding gene (van Wyk et al. 2017 ) that would target cellulose so that a null mutant of this encoding gene would result in an abolishment of any cellulase activity. However, the wild-type strain under many variations on routine cultivation conditions never exhibited any cellulase activity based on the observation that the culture supernatants never showed CMCase activity (either with the CMC-plate or liquid assay determination; data not shown). The recombineering strategy (van Kessel and Hatfull 2007) was applied to generate an M. smegmatis mutant strain in which MSMEG_6752 has been disrupted (Supplementary data, Figure S1A ). No differences in either planktonic growth (Supplementary data, Figure S1B ) or biofilm formation (Supplementary data, Figure S1C ) were observed between the mutant and the wild-type strain.
Overexpression of MSMEG_6752 prevents biofilm formation
When streaked on a minimal culture medium containing cellobiose as the sole carbohydrate source, wild-type M. smegmatis failed to grow even after 10 days of incubation (Supplementary data, Figure S2 ). Therefore, the presence of a functional cellulase along with the incapacity to grow on cellobiose, points out to a unique situation whereby MSMEG_6752 is not involved in carbohydrate acquisition but rather plays another function. Recently, M. tuberculosis was found to be unable of forming biofilms upon exogenous addition of a cellulase from Trichoderma viridae, supporting the essential role of cellulose in biofilm structure and integrity (Trivedi et al. 2016) . Whether an M. smegmatis strain that overexpresses its own MSMEG_6752 cellulase could perform similarly in preventing M. smegmatis to form a biofilm was next investigated. Using Calcofluor and Congo Red staining that preferentially bind to polysaccharides that contain β-1,4 linkages (Carder 1986 ), we show that M. smegmatis biofilms display cellulose-containing material, which is not found or at very low levels, in planktonic cultures (Figure 2A) , similarly to what was reported with M. tuberculosis (Trivedi et al. 2016) . Based on the prediction software Phobius (Käll et al. 2007) , the N-terminus of MSMEG_6752 resembles a standard secretion signal peptide, suggesting that MSMEG_6752 may be secreted. Consistently, CMCase activity was detected in the supernatants in the biofilm cultures of the MSMEG_6752-overexpression strain whereas no activity was detected in the control strain ( Figure 2B ). In addition, only the cellulose-overexpressing strain failed to produce the typical biofilm at the liquid-air interface even after 10 days of incubation ( Figure 2C ). Quantifying biofilm formation using a crystal violet (CV)-based assay confirmed this observation ( Figure 2D ). Collectively, these results suggest that MSMEG_6752 is a secreted cellulase that prevents subsequent biofilm formation.
Exposure of biofilms to MSMEG_6752 releases cellooligosaccharides and confirms presence of cellulose
We next inquired whether the secreted cellulase may be causal to the failure of the MSMEG_6752-overexpressing strain to induce biofilms. The release of soluble cello-oligosaccharides (the main end products of cellulose hydrolysis) from biofilms treated with purified MSMEG_6752 was assessed by ionic chromatography. Interestingly, cello-oligosaccharides, most particularly cellobiose, were detected from the cellulase-treated crude extracts, but not from the biofilm-defective biomass recovered from the MSMEG_6752 overexpression strain ( Figure 2E ). The identity of the peaks could be established using standards and cellulose-like substrates treated with pure MSMEG_6752. Overall, these data indicate that MSMEG_6752 hydrolyzes the biofilmassociated cellulose.
Subinhibitory concentrations of rifampicin induce cellulose production
The earlier demonstration that M. tuberculosis can make cellulose opens up intriguing questions, in particular whether this may be related to pathogenesis, linked to its particular lifestyle in the The alignment was performed with ClustalX and the display was made using the ESPript 3 server (Robert and Gouet 2014) . Residue numbering corresponds to the MSMEG_6752 sequence and the N-terminal extension of Rv0062 is omitted. Red and yellow colors indicate strictly and semi-conserved residues, respectively, while blue dots highlight the catalytic residues and/or involved in binding of carbohydrate in the crystal structure of Rv0062. (B) His-tagged-based purification of recombinant full-length MSMEG_6752 produced in E. coli. The gel shows the purity of MSMEG_6752 after a three-step purification procedure. The band below MSMEG_6752 corresponds to the cleaved thioredoxin tag. (C) pH optimum of cellulase activities of purified MSMEG_6752 and Rv0062 (on 1% CMC determined by DNS liquid assays). (D) High-performance anion-exchange chromatograms of cellulose treated with purified MSMEG_6752 (upper panel), cellulose with no enzyme control (middle panel) and cello-oligosaccharide standards (lower panel). CMC, carboxymethyl cellulose; DNS, dinitrosalicyclic. This figure is available in black and white in print and in color at Glycobiology online. infected host or as a response to stress conditions allowing adaptation to various changing conditions. To test if an antibiotic stress may affect/induce cellulose production by M. smegmatis, we assessed the effect of a subinhibitory concentration of rifampicin on M. smegmatis growth. Rifampicin at 7.5 μg/mL did not alter the growth rate of a control M. smegmatis strain ( Figure 3A) . We, therefore, assessed whether exposure of this subinhibitory dosage of rifampicin for 3 days may influence cellulose production, following staining with Congo Red. Visual inspection indicated that the rifampicin treatment of planktonic cultures resulted in a more pronounced staining than the untreated culture, suggesting that cellulose production is specifically induced upon rifampicin treatment ( Figure 3B ). Importantly, this effect was neutralized when rifampicin was added to the MSMEG_6752-overexpressing strain.
Rifampicin-treated bacteria were next exposed to either MSMEG_6752 or a cellulase cocktail from the cellulolytic fungi Trichoderma reesei (used as a positive control) and subjected to carbohydrate analysis. This led to the accumulation of cellobiose ( Figure 3C ), further substantiating that a subinhibitory antibiotic dose promotes cellulose biosynthesis. As anticipated, the highperformance anion-exchange chromatography (HPAEC) profile on untreated cultures failed to show cellobiose accumulation of ( Figure 3C ).
Since an accepted role of cellulose in bacteria is to provide some level of protection, one may hypothesize that mycobacteria produce cellulose in a similar fashion under stress conditions and that this may also contribute to protect them from antibiotics. In this regard, a mild, but significant 2-to 3-fold increased susceptibility to rifampicin was observed in the MSMEG_6752-overexpressing strain as compared to the wild-type strain, as judged by the minimal inhibitory concentration determination (10-15 and 30 μg/mL, respectively). This is consistent with the impaired growth in liquid medium of the MSMEG_6752-overexpressing strain exposed to rifampicin ( Figure 3A ). This suggests that cellulose production may exert a protective role towards antibiotic stress.
Discussion
In this study, we show how a mycobacterial GH6 endoglucanase can prevent M. smegmatis to form a biofilm, presumably due to the lack of cellulose in the extracellular polymeric substance-an aspect of mycobacterial biofilms that only recently surfaced in literature (Trivedi et al. 2016) . Whether this can be extrapolated to other mycobacteria remains to be studied, albeit all mycobacteria (except Mycobacterium leprae) appear to possess at least one cellulaseencoding gene (Mba Medie et al. 2012) . As cellulases are employed by other bacterial biofilms to detach from the biofilm (Dumitrache et al. 2013 ), it appears reasonable to expect that mycobacteria utilize their respective cellulase to perform a similar function to revert cells to a planktonic state. Exposure of M. smegmatis to a subinhibitory concentration of rifampicin leads also to cellulose production, which in turn may exert a protective role towards antibiotic stress. The gene encoding cellulose synthase is well conserved from bacteria to eukaryotes and encodes a particular family GT2 glycosyltransferase characterized by a conspicuous Q-X-X-R-W motif (Saxena et al. 1995) shown to be involved in the binding of the growing cellulose chain (Morgan et al. 2013) . A puzzling observation is that all mycobacteria lack this gene, raising the possibility that they produce their cellulose-like polymers using a different pathway. The sequencebased family classification of glycosyltransferases of the CAZy database system (http://www.cazy.org; Lombard et al. 2014) showing that the stereochemistry of the glycosidic bond is conserved within a GT family, a possible candidate mycobacterial glycosyltransferase may be found either in a known β-bond-forming GT family or in a family yet to be discovered. The possibility that mycobacteria are equipped with a nonclassical cellulose synthase system (Römling and Galperin 2015) may be related to the unique membrane architecture of mycobacteria. This speculation, however, awaits experimental investigation.
Materials and methods
Bacteria, strains and growth conditions E. coli DH5α was used for plasmid propagation, whereas E. coli HB101 strain was used to generate the knock-out plasmid. Luria Bertani (LB) medium was used with the appropriate antibiotics. For recombinant production, a preculture of E. coli BL21 Rosetta TM 2 (DE3) pLysS strain containing pET32_MSMEG_6752 was used to inoculate 6 L of LB and allowed to grow for 3 h at 37°C in a shaking incubator after which the cells were subjected to a cold-shock by placing the cultures on ice for 30 min. Isopropyl β-D-thiogalactopyranoside at 1 mM was added and the cultures were incubated overnight at 16°C. M. smegmatis mc 2 155 derived strains were routinely cultured on 7H9 or 7H10 (Difco) media supplemented with OADC and 0.05% Tween80 along with antibiotics when needed (25 µg/mL kanamycin, 150 µg/mL hygromycin). M. smegmatis strains were also grown in 7H9 medium with the pH adjusted (with KOH) to 5.0. To determine cellobiose utilization, washed M. smegmatis was streaked out on Hartmans-DeBont minimal solid medium (Hartmans and DeBont 1992) with either 2% glucose or 1% cellobiose as sole carbohydrate source.
Plasmid constructions
Primers used for PCR amplification of the cellulase-encoding genes are shown in Table S1 . The pET-series vector pET32a which carries an N-terminal thioredoxin and 6X-histidine tag was used for overexpression and eventual purification of MSMEG_6752. The fulllength MSMEG_6752 gene was PCR-amplified with flanking KpnI and BamHI restriction enzyme sites to clone into pET32a. An N-terminal Tobacco Etch Virus protease cleaving site was also added. The MSMEG_6752 gene (with NdeI and HindIII flanking restriction enzyme sites) was also cloned under the control of the hsp60 promoter in the E. coli-mycobacteria shuttle vector pVV16. Another construct was made where the hsp60 promoter was replaced with 400 bp upstream of MSMEG_6752 to generate a plasmid pVV16_ promoter+MSMEG_6752 and served to transform the M. smegmatis null-mutant strain of the MSMEG_6752 gene and create a complementation strain.
Purification of MSMEG_6752
Induced E. coli Rosetta II cells with pET32_MSMEG_6752 were resuspended in a sonication buffer (50 mM TRIS base pH 8.0, 150 mM NaCl, 5 mM β-mercaptoethanol and 1 mM benzamidine) and sonicated four times on ice for 2 min with 2 s pulses. Disrupted cells were then separated from the cell lysate by centrifugation at 35,000 × g at 4°C for 45 min. Lysates were run through a Sepharose nickel affinity column (GE Healthcare) using gravity. Beads containing the captured cellulase were then washed with 50 mM Tris base pH 8.0, 1000 mM NaCl, and 5 mM β-mercaptoethanol. The cellulase was eluted using 50 mM Tris base pH 8.0, 150 mM NaCl, 5 mM β-mercaptoethanol, 400 mM imidazole, pH 8.0. Both the 6x-histidine and thioredoxin tags were cleaved from the cellulase by adding a TEV protease to cellulase ratio of 1/50 (w/w) within the elution fraction overnight at 4°C. Tags were separated from MSMEG_6752 by running the dialyzed eluate again through a nickel-bead column. The purity of MSMEG_6752 (~32 kDa) was estimated by sodium dodecyl sulphate-polyacrylamide gel electrophoresis stained with Coomassie Brilliant Blue. Purified samples were further concentrated to a concentration of~15 mg/mL with Centricon columns prior to size-exclusion chromatography using an ENrichTM SEC 650 column.
Biofilm assays
M. smegmatis strains, grown overnight in 7H9-OADC + Tween80 media with kanamycin were adjusted to an OD 600 of 1.0 and inoculated in modified M63 media (one microliter per mL of media) in either 6, 12 or 24-well tissue culture plates. The M63 used in the study comprises of the following (per liter 13.6 g KH 2 PO 4 , 2.0 g (NH 4 ) 2 SO 4 , 0.5 mg FeSO 4 0.7 H 2 O, 5.0 g Casamino Acid (Difco), 20 g glucose, 0.11 g CaCl 2 , 0.095 g MgSO 4 ). Plates were sealed and incubated at 30°C for 4 or 5 d. A CV-based assay was also used to detect and quantify biofilm formation. After 4-to 5-days post-inoculation, mature biofilms were observed in at least the wild-type strain, the liquid was removed, allowed to dry whereafter 1 mL of 1% CV was added in each well and incubated for 10 min. The CV was removed and the wells were gently washed three times with 1× PBS. CV was then extracted by 10-min incubation with 1 mL of 95% ethanol. The absorption of extracted CV was measured on a spectrophotometer at 620 nm. Biofilm cultures along with planktonically grown wild-type M. smegmatis were also stained with Congo Red and Calcofluor (Trivedi et al. 2016 ).
Cellulase assays
Agar plates containing 1% CMC were used for visually determining crude cellulase activity. Five microliters supernatant of M. smegmatis strains were spotted onto the plates and incubated for 2 h at 37°C. Plates were then stained for 30 min with 2% Congo Red after which the plates were destained with 1× PBS. For quantification, the dinitrosalicyclic method was used (Miller 1959) . To determine the effect of different pH, the reaction was conducted in 0.05 M citratephosphate buffers (pH 3.0-7.0). D-Glucose was used to draw a standard curve (0.125-2 mg/mL) from which the nkat/mg protein was calculated.
High-performance anion-exchange chromatography
Five-day-old biofilm cultures were rigorously resuspended within their respective wells, placed in a 15 mL falcon tube and autoclaved for 15 min at 121°C. Five hundred microliters of purified MSMEG_6752 (1.0 mg/mL) were added to 500 µL of resuspended biofilm culture and incubated overnight at 37°C. Biofilm-enzyme suspensions were spun down and the soluble products were analyzed by high-performance anion-exchange chromatography (ThermoFisher) using DP2-DP6 cello-oligosaccharides (Megazyme) as standards, as described previously (Bennati-Granier et al. 2015) . The PASC substrate was prepared as reported earlier (Bennati-Granier et al. 2015) .
Drug susceptibility testing
The minimum inhibitor concentrations were determined according to the CLSI guidelines (Woods et al. 2011) . The broth microdilution method was used in Mueller-Hinton medium with an inoculum of 5 × 10 6 CFU/mL in the exponential growth phase. One hundred microliters of drug dilutions were added to 100 µL of bacterial suspension and incubated for 3 d at 30°C. Minimal inhibitory concentrations were determined with visual inspection along with measuring absorbance at 600 nm to confirm visual recording.
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Supplementary data is available at Glycobiology online.
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